Related Articles
Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer
Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases
Two consecutive days of treatment with liposomal cisplatin in non-small cell lung cancer
Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: A phase II trial